Gallbladder contractility in patients with cirrhotic versus malignant ascites
✍ Scribed by Ramazan Sari; Bulent Yildirim; Alper Sevinc; Funda Bahceci; Fatih Hilmioglu
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 104 KB
- Volume
- 30
- Category
- Article
- ISSN
- 0091-2751
No coin nor oath required. For personal study only.
✦ Synopsis
Purpose:
The aim of this study was to evaluate differences in gallbladder contractility by measuring gallbladder wall thickness, fasting and residual gallbladder volume, and gallbladder ejection fraction in patients with cirrhotic and malignant ascites.
Methods:
Twenty-four patients (16 women and 8 men) with malignant ascites (2 cervical, 2 colon, 2 stomach, 6 pancreatic, and 12 ovarian carcinomas), aged 59 +/- 12 years, and 26 patients (14 women and 12 men) with cirrhotic ascites, aged 57 +/- 16 years, were included in the study. after patients fasted overnight for 8 hours, gallbladder wall thickness, fasting gallbladder volume, and gallbladder volume and ejection fraction were measured sonographically at 10, 20, 30, 40, 50, 60, 70, 80, and 90 minutes after ingestion of a standard liquid test meal.
Results:
The mean gallbladder wall thickness was higher in patients with cirrhotic ascites than in those with malignant ascites (5.5 +/- 1.5 mm [standard deviation] versus 3.1 +/- 0.6 mm, respectively; p < 0.001). the mean fasting gallbladder volume was also higher in patients with cirrhotic ascites than in those with malignant ascites (27.3 +/- 11.5 cm(3) versus 17.6 +/- 8.9 cm(3); p < 0.05). patients with cirrhotic ascites had significantly higher mean postprandial gallbladder volumes and ejection fractions than did those with malignant ascites at all times except 10 minutes after the meal (p < 0.05).
Conclusions:
Our findings suggest that gallbladder contractility is greater in patients with cirrhotic ascites than in patients with malignant ascites.
📜 SIMILAR VOLUMES
## Abstract ## Purpose. To determine gallbladder volume with sonography during fasting and in response to a fatty meal in patients with spinal cord injuries (SCIs) and compare the results with those obtained in healthy controls. ## Method. Forty‐three patients with SCI and 40 healthy volunteers
The presence of CA 125, an ovarian cancer-associated antigen, was assessed in serum and ascites from patients with ovarian cancer (n = 47), hepatocellular carcinoma (n = 21), and liver cirrhosis (n = 40). Abnormal levels of serum CA 125 were observed in 49% of ovarian cancer patients, and in 89% of
This study was supported in part by the Fondo de Investigationes Sanitarias de la Seguridad Social (FISS 91/0374) and Fundacio Catalana per a 1'Estudi de les Malalties del Fetge. Dr. Luca was a recipient of a grant fellowship by Fundacio Privada Clinic per a la Recerca Biomedica.